| Literature DB >> 24427673 |
Rakesh Singh Meena1, Deepali Meena1, Yogesh Aseri1, B K Singh1, P C Verma1.
Abstract
The aim of our study is to understand the concept of unified airway disease, to know the advantage of this concept in the diagnosis and treatment of allergic rhinitis, chronic rhino-sinusitis and asthma, to know its impact on practice of otolaryngologists, to motivate the otorhinolaryngologist to apply this concept in diagnosis and treatment. This article is based on our experience on (20 cases) chronic rhino-sinusitis and asthma, and observations and results from various literatures. Implement of the concept of unified airway disease and ability to translate its principles into successful diagnostic and treatment strategies can enhance the practice of otolaryngology. The end result is the potential for improved patient care. In our study 80% cases have reduced frequency of symptoms and all (100%) cases having improved night time symptoms thus the use of short-acting beta2 agonist to control the asthma symptoms decreases.Entities:
Keywords: Chronic rhino-sinusitis (CRS); Immunoglobulin-E (IgE); Interleukin (IL); Para nasal sinuses (PNS); Short-acting beta2 agonist- salbutamol; Unified airway disease (UAD)
Year: 2012 PMID: 24427673 PMCID: PMC3738764 DOI: 10.1007/s12070-012-0495-8
Source DB: PubMed Journal: Indian J Otolaryngol Head Neck Surg ISSN: 2231-3796